29.07.2015 00:03:02
|
After-market Movers For July 28 (RUBI, GILD, AKAM, TWTR, YELP)
(RTTNews) - Gainers:
Rubicon Project, Inc. (RUBI) rose 15 percent to $17.75. The company's second quarter net loss widened from the year-ago quarter, while its non-GAAP earnings per share topped analysts' estimate. Revenue increased 88 percent year-over-year and came above the consensus estimate.
Gilead Sciences Inc. (GILD) gained 3 percent to $116.49. The company's second quarter profit and revenues improved from the year-ago quarter.
Decliners:
Akamai Technologies, Inc. (AKAM) fell 9 percent to $66.50. The company's second quarter earnings missed analysts' estimate, while its revenue managed to come above the consensus estimate.
Twitter, Inc. (TWTR) declined 6 percent to $34.33. The company's second quarter net loss narrowed from the year-ago quarter, while its adjusted earnings per share topped Street view. Revenue improved 61 percent and came above the consensus estimate. The company forecast third quarter revenue in line with estimate and raised the low end of its full year 2015 revenue guidance.
Yelp Inc. (YELP) plunged 16 percent to $28.15. The company slipped to a loss in its second quarter, depite 51 percent growth in net revenue. The company forecast third quarter revenue below the consensus estimate and also lowered its 2015 outlook based on slower sales headcount growth and the elimination of its brand advertising product.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Gilead Sciences Inc.mehr Nachrichten
16:03 |
NASDAQ Composite Index-Wert Gilead Sciences-Aktie: So viel hätten Anleger mit einem Investment in Gilead Sciences von vor einem Jahr verdient (finanzen.at) | |
15.11.24 |
NASDAQ Composite Index-Papier Gilead Sciences-Aktie: So viel hätte eine Investition in Gilead Sciences von vor 10 Jahren gekostet (finanzen.at) | |
08.11.24 |
NASDAQ Composite Index-Wert Gilead Sciences-Aktie: So viel hätten Anleger an einem Gilead Sciences-Investment von vor 5 Jahren verdient (finanzen.at) | |
07.11.24 |
Gewinne in New York: NASDAQ 100 präsentiert sich letztendlich fester (finanzen.at) | |
07.11.24 |
NASDAQ 100-Handel aktuell: So performt der NASDAQ 100 am Donnerstagnachmittag (finanzen.at) | |
07.11.24 |
NASDAQ 100 aktuell: So steht der NASDAQ 100 mittags (finanzen.at) | |
07.11.24 |
Freundlicher Handel in New York: NASDAQ 100 zum Start des Donnerstagshandels in Grün (finanzen.at) | |
05.11.24 |
Ausblick: Gilead Sciences öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Gilead Sciences Inc.mehr Analysen
Aktien in diesem Artikel
Akamai Inc. | 88,89 | 2,60% | |
Gilead Sciences Inc. | 86,62 | 1,26% | |
Yelp Inc. | 34,40 | 1,18% |